Predict your next investment

PainDrainer company logo
INTERNET | Internet Software & Services / Health & Wellness
paindrainer.com

See what CB Insights has to offer

Founded Year

2018

Stage

Series A | Alive

Total Raised

$2.03M

Last Raised

$1.36M | 1 mo ago

Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About PainDrainer

PainDrainer develops cloud-based applications for self-management of chronic pain, using multilevel artificial intelligent systems.

PainDrainer Headquarter Location

Medicon Village bldg 301 Scheelevägen 2

Lund, 223 63,

Sweden

Latest PainDrainer News

She is the new CEO of PainDrainer

Aug 16, 2019

She is the new CEO of PainDrainer Search for content, post, videos The e-health company has appointed Anki Malmborg Hager as their new CEO. PainDrainer has since 2018 developed a web-based application for self-management of chronic pain improving the quality of life by giving individual prognosis on how to minimize the pain level through artificial intelligence. The company is now performing several clinical studies both in USA and Sweden, with a focus to demonstrate the value of its web-based application. “PainDrainer is a very interesting start-up company that has developed an absolutely unique web-based application for self-management of chronic pain. Artificial intelligence and eHealth are two of the latest and most promising technologies that will rule much of our future, and I am excited to explore the potential of this type of business. I very much look forward to being part of this exciting company and build value in the coming years,” says Anki Malmborg Hager. Long-standing experience Anki Malmborg Hager has a long-standing experience of leading life science companies in their early start-up phases, with SenzaGen being the most recent achievement. At SenzaGen she was CEO for 5 years and took the company from a market cap of 5 to 500 million SEK. Prior to SenzaGen, Anki Malmborg Hager was acting CEO of Cantargia and Diaprost. She holds a doctorate degree in Immunotechnology from Lund University as well as a Pharma-MBA from Falconbury. “I am very pleased to welcome Anki Malmborg Hager as CEO during this expansive growth phase of our innovation journey. She has solid commercial background in the life science sector and will add valuable expertise of developing this exciting and disruptive eHealth company. She also has exactly the necessary skills, vision and determination to build on the foundations that we laid so far,” says Carl Borrebaeck, acting CEO today. Anki Malmborg Hager will start as CEO on September 1, focusing on the commercial development of PainDrainer, using its evidence based clinical data. Carl Borrebaeck will then take the role of Chairman of the Board. Photo: Peter Hamlin March 31, 2017 Idogen has recruited Dr. Steven Glazer to the position of Chief Medical Officer (CMO) commencing the 1st of April. The company hopes that this appointment means a strengthening of the organization for future clinical studies, initially in hemophilia A. “I look forward to working with Idogen and hemophilia again –… February 15, 2018 Researchers from Uppsala University and Karolinska Institutet in Sweden present in the journal Nature a detailed molecular atlas of the cells that form the brain’s blood vessels and the life-essential blood-brain barrier. The atlas provides new knowledge regarding the functions of the cells and the barrier, and clues to which cell types… February 3, 2019 Claire Adlam, PR Manager at Global Pharma Consulting, shares her experiences from Sweden’s only pavilion at Arab Health 2019. For the third year in a row, Swedish thought leaders, innovators and organisations were widely represented in Sweden’s country pavilion at Arab Health. Speaking at the inauguration of The Innovation Pavilion… September 30, 2014 Karolinska Development has announced that CEO Torbjörn Bjerke leaves the company. Bjerke will be replaced by Klaus Wilgenbus until a new permanent CEO has been appointed. Torbjörn Bjerke leaves his position as CEO on September 30, 2014, and Klaus Wilgenbus steps down from his Board position in Karolinska Development and assumes his new duties with… Editor in Chief

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PainDrainer

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PainDrainer is included in 1 Expert Collection, including Digital Health.

D

Digital Health

12,256 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.